Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Indust/Producer Dur Alphadex First Trust (FXR)

$37.31 0.00 (0.00%)

20:00 EDT FXR Stock Quote Delayed 30 Minutes

Volume:

Previous Close $37.31

Market Cap 1.57B

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 37.31 - 37.31

52-Week Range 25.14 - 46.60

Dividend & Yield 0.28 (0.74%)

FXR Stock Predictions, Articles, and Indust/Producer Dur Alphadex First Trust News

From InvestorPlace
From the Web

5 ETFs to Buy as Q2 GDP Growth Hits 4-Year High of 4.1%

By Zacks Investment Research Jul 30, 2018

While most of the ETFs will likely benefit on the astounding Q2 GDP numbers, we have highlighted five funds with a solid Zacks ETF Rank #1 (Strong Buy) or 2 (Bu....

Top-Ranked Sector ETFs & Stocks From Top Industries

By Zacks Investment Research Feb 26, 2018

Investors could be well served by looking at the ETFs and stocks of the top-ranked sectors. Compare Brokers...

The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500

From Benzinga May 7, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...

The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace

From Benzinga May 3, 2020

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

20 Healthcare Stocks Moving In Friday's Pre-Market Session

From Benzinga May 1, 2020

Gainers • Medigus, Inc. (NASDAQ:MDGS) stock moved upwards by 70.21% to $4 during Friday's pre-market session. • Genetic Technologies, Inc. (NASDAQ:GENE) shares...

Is Sunesis Pharmaceuticals (SNSS) Stock Outpacing Its Medical Peers This Year?

From Zacks Investment Research Apr 2, 2020

Is (SNSS) Outperforming Other Medical Stocks This Year?

Is Sunesis Pharmaceuticals (SNSS) Outperforming Other Medical Stocks This Year?

From Zacks Investment Research Mar 17, 2020

Is (SNSS) Outperforming Other Medical Stocks This Year?

Earnings Beat: Sunesis Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

From Simply Wall St Mar 13, 2020

There’s been a major selloff in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares in the week since it released its annual report, with the stock down 62% to US$0.38. Revenues of US$2.1m<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-snss/sunesis-pharmaceuticals/news/earnings-beat-sunesis-pharmaceuticals-inc-just-beat-analyst-forecasts-and-analysts-have-been-lifting-their-forecasts/">Read More...</a></div>